Skip to main content

Alloxan derivatives as a tool for the elucidation of the mechanism of the diabetogenic action of alloxan

  • Chapter
Lessons from Animal Diabetes VI

Part of the book series: Rev.Ser.Advs.Research Diab.Animals (Birkhäuser) ((RSARDA,volume 6))

Abstract

In 1818, the Italian Brugnatelli obtained a substance from the oxidation of uric acid that he named ossieritrico. This name, from the Greek “to make red,” referred to the property of the substance to stain the skin a characteristic red color.1 Twenty years later, the German chemists, Wöhler and Liebig, studied uric acid oxidation in detail and obtained the same compound, which they named alloxan, apparently from conflation of the words allantoin and Oxalsäure.2 The early history of alloxan has been reviewed in detail elsewhere.3 Alloxan became generally accepted as the common name for this substance. The compound as synthesized via aqueous workup is a so-called hydrate, actually a gem-diol. The systematic name of this substance is 5,5,-dihydroxy-2,4,6 (1H, 3H, 5H)-pyrimidinetrione.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Subscribe and save

Springer+ Basic
$34.99 /Month
  • Get 10 units per month
  • Download Article/Chapter or eBook
  • 1 Unit = 1 Article or 1 Chapter
  • Cancel anytime
Subscribe now

Buy Now

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 129.00
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 169.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 169.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

Similar content being viewed by others

References

  1. Brugnatelli G. Sopra i cangiamenti che avvengono nell’ossiurico (ac. urico) trattato coll’ossisettonoso (ac. nitroso). G Fis Chim 117–29, 1818.

    Google Scholar 

  2. Wöhler F, Liebig J. Untersuchungen über die Natur der Harnsäure. Ann Pharm 26:241–340, 1838.

    Article  Google Scholar 

  3. Lenzen S, Panten U. Alloxan: History and mechanism of action. Diabetologia 31:337–42, 1988.

    Article  PubMed  CAS  Google Scholar 

  4. Dunn JS, Sheehan HL, McLetchie NGB. Necrosis of islets of Langerhans produced experimentally. Lancet 244:484–7, 1943.

    Google Scholar 

  5. Webb JL. Alloxan. In: Enzyme and metabolic inhibitors. Webb JL, ed. Academic Press, New York, pp 367–119, 1966.

    Google Scholar 

  6. Cooperstein SJ, Watkins D. Action of toxic drugs on islet cells. In: The islet of Langerhans. Cooperstein SJ, Watkins D, eds. Academic Press, New York, pp 387–425, 1981.

    Google Scholar 

  7. Oberley LW. Free radicals and diabetes. Free Radic Biol Med 5:113–24, 1988.

    Article  PubMed  CAS  Google Scholar 

  8. Biltz H. Alloxan-anhydrid und seine Methylderivate. Ber Dtsch Chem Ges 45:3659–75, 1912.

    Article  Google Scholar 

  9. Biilmann E, Berg N. Über die Reduktionspotentiale der Alloxantine und über die Darstellung der Alloxane und Alloxantine. Chem Ber 63:2188–204, 1930.

    Google Scholar 

  10. Brückmann G, Wertheimer E. Diabetogenic action of alloxan derivatives. Nature 155:267–8, 1945.

    Article  Google Scholar 

  11. Hidy PH. Structural requirements for diabetogenic action in alloxan and related compounds. J Biol Chem 163:307–11, 1946.

    PubMed  CAS  Google Scholar 

  12. Bernhard K, Favarger M, Renold A, Spühler O. Beiträge zur Alloxan-Glucosurie. Helv Chim Acta 30:1666–72, 1947.

    Article  PubMed  CAS  Google Scholar 

  13. Brückmann G, Wertheimer E. Alloxan studies: The action of alloxan homologues and related compounds. J Biol Chem 168:241–56, 1947.

    PubMed  Google Scholar 

  14. Brückmann G, Isaacs SD. Preparation and properties of new derivatives of alloxan. J Am Chem Soc 71:390–2, 1949.

    Article  PubMed  Google Scholar 

  15. Gabathuler J. Emil Abderhalden. Sein Leben und Werk. Buchhandlung Ribaux AG, St. Gallen, pp 1–362, 1991.

    Google Scholar 

  16. Renold AE. Der Alloxan-Diabetes. Zürich, Dissertation, pp 1–45, 1948.

    Google Scholar 

  17. Lenzen S, Munday R. Thiol-group reactivity, hydrophilicity, and stability of alloxan, its reduction products and its N-methyl derivatives and a comparison with ninhydrin. Biochem Pharmacol 42:1385–91, 1991.

    Article  PubMed  CAS  Google Scholar 

  18. Munday R, Ludwig K, Lenzen S. The relationship between physicochemical properties and the biological effects of alloxan and several N-alkyl substituted alloxan derivatives. J Endocrinol 139:153–63, 1993.

    Article  PubMed  CAS  Google Scholar 

  19. Jörns A, Munday R, Tiedge M, Lenzen S. Comparative toxicity of alloxan, N-alkyl-alloxans and ninhydrin to ob/ob mouse pancreatic islets in vitro, unpublished.

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 1996 Birkhäuser Boston

About this chapter

Cite this chapter

Lenzen, S., Tiedge, M., Jörns, A., Munday, R. (1996). Alloxan derivatives as a tool for the elucidation of the mechanism of the diabetogenic action of alloxan. In: Shafrir, E. (eds) Lessons from Animal Diabetes VI. Rev.Ser.Advs.Research Diab.Animals (Birkhäuser), vol 6. Birkhäuser Boston. https://doi.org/10.1007/978-1-4612-4112-6_8

Download citation

  • DOI: https://doi.org/10.1007/978-1-4612-4112-6_8

  • Publisher Name: Birkhäuser Boston

  • Print ISBN: 978-1-4612-8658-5

  • Online ISBN: 978-1-4612-4112-6

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics